APOE and atherosclerosis: Plasma interleukin-35 (IL-35) is increased in ApoE-/- mice and patients with hypercholesterolemia, and IL-35 suppresses mitochondrial ROS-induced H3K14 acetylation, which inhibits endothelial activation and alleviates the development of atherosclerosis.434